WRS Westar Energy Westar Energy First Mortgage Bonds 6.10% Series Due May 15, 2047

INDIANAPOLIS, May 2 /PRNewswire-FirstCall/ -- Windrose Medical Properties Trust (NYSE:WRS), a self-managed specialty medical properties REIT, announced today that its Board of Trustees declared a quarterly cash dividend of $0.235 per share for the first quarter ended March 31, 2006. The first quarter dividend represents a 4.4% increase over the prior quarter. The dividend is payable on May 25, 2006 to shareholders of record on May 15, 2006. Windrose also announced today that its Board of Trustees declared a quarterly dividend of $0.4521 per 7.5% Series A cumulative convertible preferred share. This dividend will be payable on May 22, 2006 to preferred shareholders of record on May 5, 2006. About Windrose Windrose is a self-managed real estate investment trust (REIT) based in Indianapolis, Indiana with offices in Nashville, Tennessee. Windrose was formed to acquire, selectively develop and manage specialty medical properties, such as medical office buildings, ambulatory surgery centers, outpatient treatment diagnostic facilities, physician group practice clinics, specialty hospitals and treatment centers. Safe Harbor Some of the statements in this news release constitute forward-looking statements. Such statements include, in particular, statements about our beliefs, expectations, plans and strategies and the payment of dividends that are not historical facts. You should not rely on our forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties, assumptions and changes in circumstances, many of which are beyond our control, which may cause our actual results to differ significantly from those expressed in any forward-looking statement. The factors that could cause actual results to differ materially from current expectations include financial performance and condition of our tenants, adverse changes in healthcare laws, changes in economic and general business conditions, competition for specialty medical properties, our ability to finance our operations, the availability of additional acquisitions, regulatory conditions and other factors described from time to time in filings we make with the Securities and Exchange Commission. The forward-looking statements contained herein represent our judgment as of the date hereof and we caution readers not to place undue reliance on such statements. We do not undertake to publicly update or revise any forward-looking statement whether as a result of new information, future events or otherwise. Contact: Windrose Medical Properties Trust Fred Farrar President and COO 317 860-8213 Investors/Media: The Ruth Group Stephanie Carrington/Jason Rando 646 536-7017/7025 DATASOURCE: Windrose Medical Properties Trust CONTACT: Fred Farrar, President and COO of Windrose Medical Properties Trust, +1-317-860-8213; or Investors, Stephanie Carrington, +1-646-536-7017, , or Media, Jason Rando, +1-646-536-7025, , both of The Ruth Group, for Windrose Medical Properties Trust

Copyright